A new study on the chemicals in the latest batch of legally sold ‘synthetic highs’ has found what looks like an unintended hybrid drug.

As regular Mind Hacks readers will know, I’m a keen watcher of the murky ‘legal high’ market.

We seem to be in the unprecedented position where sophisticated grey-market pharmacologists are rapidly inventing completely new-to-science drugs in underground labs for thrill-seeking punters.

These synthetic drugs have typically come in two types: ‘fake pot’ – made from synthetic cannabinoids and stimulants, usually derived from cathinone.

A study just published in Forensic Science International looked at the chemicals in a new wave of ‘fake pot’ herbal highs sold over the internet.

Firstly, the research identified 12 new synthetic cannabinoids. That’s twelve completely new untested cannabis-like drugs. The turnover in the market is both stunning and scary.

Curiously though, one ‘legal pot’ sample contained both a new synthetic cannabinoid (identified as URB-754) and a cathinone (4-Me-MABP) in it.

What was most surprising though, was that these substances had chemically reacted with one another to create a completely new combination drug. It has the chemical name (N,5-dimethyl-N-(1-oxo-1-(p-tolyl)butan-2-yl)-2-(N′-(p-tolyl)ureido)benzamide) if you want to sound sexy.

In other words, while the makers intended to put both a cannabinoid and a stimulant in the same product, they probably never knew that the substances had chemically combined to produce a hybrid compound with completely unknown properties.

The legal high market is becoming an informal opt-in drug-testing experiment with paying subjects.



Link to locked study.